Suggested Topics within your search.
Suggested Topics within your search.
Adult
1
COVID-19
1
COVID-19 Testing
1
COVID-19 Vaccines
1
COVID-19 testing
1
Drug Costs
1
Humans
1
Immunization, Secondary
1
Note
1
SARS-CoV-2 vaccine
1
United States
1
ad26.cov2.s vaccine
1
adult
1
biontech covid 19vaccine
1
control strategy
1
coronavirus disease 2019
1
cost benefit analysis
1
diagnosis
1
diagnostic error
1
disease severity
1
disease transmission
1
drug cost
1
economic development
1
economic efficiency
1
economic stability
1
economics
1
elasomeran
1
health care access
1
health care availability
1
health care cost
1
-
1
-
2by Sohil Pothiawala“... of Moderna COVID-19 vaccine. Considering this development of symptoms 2 weeks after the second dose...”
Published 2021-08-01
Get full text
Article -
3
-
4
-
5
-
6
-
7by Davide Ferorelli, Lorenzo Spagnolo, Maricla Marrone, Serena Corradi, Maria Silvestre, Federica Misceo, Francesco Paolo Bianchi, Pasquale Stefanizzi, Biagio Solarino, Alessandro Dell’Erba, Silvio Tafuri“.... After the availability of the first COVID-19 vaccines (Comirnaty Pfizer-BioNTech and Moderna COVID19...”
Published 2021-04-01
Get full text
Article -
8by Gabriella Smith“... manufacturing, even temporarily. Catalent was just one of many Moderna COVID-19 vaccine manufacturers...”
Published 2021-10-01
Get full text
Article -
9“... as the Pfizer-BioNTech and the Moderna COVID19 vaccines are being administered throughout the United States...”
Get full text
Article